Lilly's diabetes drug works as well as Novo Nordisk's blockbuster Victoza in study
This article was originally published in Scrip
Executive Summary
Eli Lilly said its unapproved long-acting treatment dulaglutide worked as well as Novo Nordisk’s big-selling therapy Victoza controlling diabetics’ blood-sugar levels in a study.